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DISCUSSION 
INTRODUCTION 
Post-tonsillectomy pain traditionally has been controlled with acetaminophen in 
combination with a narcotic, such as codeine, hydrocodone, or oxycodone. Deaths 
due to respiratory depression have been reported in children given codeine post-
tonsillectomy.1 Many of the deaths have been in children who possess forms of the 
liver microenzyme CYP2D6 that make them extensive or ultrarapid metabolizers of 
codeine.2 
  
The current concerns regarding rapid metabolism of codeine products in children 
following tonsillectomy3 have led to widespread reconsideration of post-
tonsillectomy pain management regimens for the pediatric population. Non-
steroidal anti-inflammatory drugs (NSAID), specifically ibuprofen, have gained favor 
as an alternative to narcotics for postoperative pain control. While NSAIDs provide 
adequate post-tonsillectomy analgesia,4 their routine use remains controversial as 
NSAIDs also cause platelet dysfunction that may lead to increased risk of post-
tonsillectomy hemorrhage (PTH). The clinical impact of this potentially increased 
bleeding risk with NSAID use remains unclear.  
  
This study examines whether the use of ibuprofen in children post-intracapsular 
tonsillectomy affects the likelihood of clinically significant bleeding. The incidence of 
PTH requiring either non-surgical or surgical intervention is compared in children 
who received ibuprofen and acetaminophen versus those who received 
acetaminophen with narcotic for post-tonsillectomy pain. Secondarily, the incidence 
of emergency department (ED) evaluation for pain or poor oral intake is examined.  
METHODS 
There were 449 patients studied who underwent tonsillectomy or 
adenotonsillectomy at N/AIDHC between 2011 and 2013 (NSAID group). Of these, 
244 (54.3%) were female, and 205 (45.7%) were male; the mean age at time of 
surgery was 9.5 years (SD, 3.2 years). The secondary data set examined 1731 
patients who underwent intracapsular tonsillectomy or adenotonsillectomy at 
N/AIDHC between 2002 and 2005 (Narcotic group). Forty-eight percent were 
female, and 52% were male; the mean age at time of surgery was 6 years.  
  
There were 7 (3.8%) episodes of secondary PTHs in the NSAID group and 19 
(1.1%) episodes of secondary PTHs in the Narcotic group, a difference that was 
statistically significant (P < 0.0001, OR 3.5, 95% CI 1.7–7.2). In the NSAID group, 
seven (1.6%) required control of their PTH in the operating room, as compared to 
eight (0.5%) in the Narcotic group. The increased rate of PTH requiring control in 
the operating room was significantly higher in the NSAID group (P = 0.01, OR 3.4, 
95% CI 1.1–10.1). In the NSAID group, 161 patients received ketorolac 
postoperatively for pain control, and 288 did not. In those who received ketorolac, 
there were four (4.3%) episodes of primary PTH and five (3.1%) episodes of 
secondary PTH. Of those not receiving ketorolac, there were five (3.1%) with 
primary PTH and 12 (4.2%) with secondary PTH. Administration of ketorolac was 
found to have no statistically significant effect on rates of primary (P = 0.73) or 
secondary (P = 0.80) PTH.  
  
In the NSAID group, 19 of 512 (3.71%) patients were evaluated in the ED for pain 
or poor oral intake. In the narcotic group, 52 of 1731 (3.79%) were admitted for 
dehydration. The incidence of ED evaluation for pain or poor oral intake was not 
statistically significant between groups (P = 0.23).  
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Several studies have been undertaken in recent years to evaluate the increased 
risk of PTH in children using NSAIDs, and suggest that there is evidence that 
NSAIDs increase this risk.6-10 In a 2003 study by Marrett, the preoperative use of 
NSAIDs was associated with increased risk of reoperation for hemostasis versus 
those who received placebo or narcotic.6 A study by Møiniche that same year found 
that postoperative NSAID use leads to increased likelihood of having a PTH 
requiring reoperation.7 A more recent systematic review and meta-analysis by 
Riggin10 again found that patients receiving NSAIDs in the postoperative period 
have an increased risk for PTH. Limitations of these studies include the use of 
several different NSAID agents and inclusion of both pediatric and adult patients.  
  
The current study examines differences in a pediatric population who underwent 
intracapsular tonsillectomy and for whom parents received standard verbal and 
written instruction regarding the recommended postoperative pain regimen. In our 
population, patients receiving postoperative ketorolac and ibuprofen had a 
statistically significant higher rate of secondary PTH with no increased bleeding 
attributed to use of ketorolac. Despite the observed increase in PTH, the overall 
rate of PTH and PTH requiring operative control remain within the national 
average. The relative increase in PTH must be weighed against the risks of 
respiratory depression associated with postoperative codeine use, especially in the 
pediatric sleep-disordered breathing population.  
  
A limitation of our study involves variation in the dosage of ibuprofen administered; 
with some surgeons prescribing 5 mg/kg/dose and others 10 mg/kg/dose. As a 
retrospective study, the number of NSAID doses actually taken also remains 
unknown. Both limitations will be addressed in a future prospective study. Finally, it 
is noteworthy that in the narcotic group, children evaluated in the ED for 
hyperemesis thought to be due to codeine were not considered in the dataset. As 
such, it is possible that the difference in the number of children in the NSAID group 
and narcotic group presenting to the ED for nausea and vomiting, noted to be not 
significantly different, is underestimated. 
A sample of children who underwent tonsillectomy or adenotonsillectomy for 
infections or sleep-disordered breathing at Nemours/Alfred I. duPont Hospital for 
Children (N/AIDHC) between 2011 and 2013 was reviewed. Intracapsular 
tonsillectomy was performed on all children. Postoperatively, families received 
verbal and written instruction to use alternating acetaminophen and ibuprofen as 
needed for their child’s pain. This cohort of children was then compared to a cohort 
of children who underwent intracapsular tonsillectomy or adenotonsillectomy at 
N/AIDHC between 2002 and 2005 who used acetaminophen with codeine or 
hydrocodone as needed for pain.5  Data collected included patient age and gender; 
indication for surgery; use of postoperative ketorolac; occurrence of primary or 
secondary PTH; evaluation in the ED for PTH, pain, or poor oral intake; and need 
for reoperation due to secondary PTH. Children with known coagulopathies were 
excluded. The association between categorical variables was expressed as odds 
ratios (OR) with 95% confidence intervals. Differences in the relative proportions 
between categorical variables were analyzed using Fisher exact test and chi-
square analysis, as appropriate.  
CONCLUSION 
The debate on the ideal pain control regimen for children post-tonsillectomy 
persists. Our review suggests that NSAIDs increase the likelihood of clinically 
significant, secondary PTH; the rate of secondary PTH observed, however, still falls 
within national averages. Conversely, NSAIDs appear to provide adequate pain 
relief, resulting in at least an equivalent incidence of ED evaluation for poor oral 
intake as compared to narcotic, and not conferring an increased risk for 
suppression of respiratory drive. Future studies aim to evaluate whether the 
number of doses and the amount of ibuprofen given per dose affects risk for PTH 
and to continue to examine the effects of ketorolac on primary and secondary PTH.  
Ketorolac Used  
(n = 161) 
No Ketorolac Used  
(n = 288) 
P value 
Primary PTH 4 (4.3%) 5 (1.7%) 0.73 
Secondary PTH 5 (3.1%) 12 (4.2%) 0.80 
Table 2. Postoperative Ketorolac Use and Post-Tonsillectomy Hemorrhage 
Narcotic  
(n = 1731) 
NSAIDs 
(n = 449) 
P value 
Secondary PTH 19 (1.1%) 17 (3.8%) < 0.0001 
Secondary PTH 
requiring operative 
control 
8 (0.5%) 7 (1.6%) 0.01 
Dehydration 52 (3%) 19 (4.2%) 0.23 
Table 1. Comparison of Outcome Measures for Narcotic and NSAID Groups 
RESULTS ABSTRACT 
Tonsillectomy with or without adenoidectomy is one of the most frequently performed surgeries in the 
United States, with over 500,000 performed annually. Post-tonsillectomy hemorrhage is one of the most 
feared complications; thus, medications that could increase the risk of postoperative bleeding traditionally 
have been avoided. With recent FDA guidelines encouraging a departure from codeine-based medications 
in pediatric patients undergoing tonsillectomy, we examined the use of ibuprofen for post-tonsillectomy 
pain control. The records of 449 children who underwent tonsillectomy and received ibuprofen for 
postoperative pain control were reviewed and compared to a cohort of 1731 children who received 
codeine for pain postoperatively. Outcomes measured included rates of secondary post-tonsillectomy 
hemorrhage (PTH), secondary PTH requiring operative control, and emergency room evaluation for 
dehydration. Use of ibuprofen after pediatric intracapsular tonsillectomy was found to be associated with a 
statistically significant increase in secondary PTH and secondary PTH requiring operative 
control; however, ibuprofen was found to provide pain control that is at least equivalent to narcotic. Rates 
of secondary PTH with postoperative ibuprofen use remain within the national average. We propose that, 
despite the increased risk of bleeding, the use of ibuprofen is appropriate for use postoperatively in 
pediatric tonsillectomy patients, given its ability to control pain and lack of respiratory depression effects. 
